[Today's focus]

Xiaopeng Motor-W (09868.HK) and Volkswagen Group signed a strategic cooperation framework agreement on electronic and electrical architecture technology

Xiaopeng Motor-W (09868.HK) and Volkswagen Group jointly announced that Xiaopeng Motor and Volkswagen Group have signed a strategic cooperation framework agreement on electronic and electrical architecture (“electronic and electrical architecture”) technology.

The industry-leading electronic and electrical architecture independently developed by Xiaopeng Motor is the core technology of its vertically integrated software and hardware technology. Thanks to this advanced electronic and electrical architecture, software such as intelligent driving assistance software and connected vehicle operating systems can be decoupled from the underlying hardware and vehicle platform to enable rapid cross-platform software iteration. Xiaopeng Motor's latest generation electronic and electrical architecture uses an architecture based on central computing and domain controllers, providing a high-performance in-vehicle computing environment and a competitive cost structure. The electronic and electrical architecture supports Gigabit Ethernet high-speed data transmission between the central domain and the intelligent driving assistance domain controller. A large number of electronic control units are integrated into the domain controller, thus achieving a highly integrated architecture and competitive cost structure. The electronic and electrical architecture also supports efficient full-vehicle OTA, providing high-speed OTA for end user vehicles and off-line vehicles.

In this strategic cooperation on electronic and electrical architecture technology, Xiaopeng Motor and Volkswagen Group will jointly develop and integrate it into Volkswagen's CMP platform in China based on Xiaopeng Motor's latest generation electronic and electrical architecture. The electronic and electrical architecture jointly developed by the two parties is expected to be applied to Volkswagen brand electric models manufactured in China from 2026.

“The common pursuit of technological innovation brought Xiaopeng Motors and Volkswagen together. The two sides will continue to demonstrate the strengths and contribute to our strategic partnership. This strategic partnership, based on our industry-leading electronic and electrical architecture technology, has taken our strategic partnership to a new level and is based on a larger strategic partnership. “Through cooperation, our smart electric vehicle products will be highly competitive in terms of technology and cost,” said Xiaopeng He, Chairman and CEO of Xiaopeng Motors.

VW Group's managing director in China, Chairman and CEO of Volkswagen Group (China), said: “Adhering to the 'in China, for China' strategy, we are continuously improving Volkswagen Group's innovative strength in China. By expanding cooperation with Xiaopeng Motors and deeply integrating into the Chinese industrial ecosystem, we can more quickly meet the needs of Chinese customers for products. The partners give full play to their respective advantages to jointly achieve higher efficiency, better cost structure and faster R&D speed. In the rapidly changing Chinese automotive market, significant cost efficiency and a rapid pace of development are critical to maintaining competitiveness. The effective steps we have taken will drive the Group to continue to lead change in the era of intelligent connected vehicles.”

[Important matters]

Bolton, China (03318.HK): Shenzhen Bolton owns a plot of land in Shenzhen to be expropriated

Elegant Optics (00907.HK) and Emperor Film entered into a three-year main participation agreement relating to the investment of Emperor Film's series or multiple film project portfolios

[Financial results]

China Building Materials (03323.HK) Profit Alert: Equity holders are expected to account for losses of about 1.3 billion yuan in the first quarter

Anta Sports (02020.HK): Retail sales of Anta brand products recorded a positive year-on-year increase in the number of units in the first quarter

[Operational data]

Sunshine Insurance (06963.HK)'s original premium revenue in January-March reached 44.992 billion yuan

[Pharmaceutical Innovation]

Yiming Angko-B (01541.HK): IMM01 (tidapecip) was approved by the State Drug Administration for phase III clinical trial program

Fosun Pharmaceutical (02196.HK): Fuhong Hanlin was approved for drug clinical trials

Fosun Pharmaceutical (02196.HK): Application for registration of sodium phosphonate injection was accepted by the State Drug Administration

[Acquisition and sale]

21st Century Education (01598.HK) spent 17.4 million yuan to successfully compete for land use rights in Gaoyi County, Shijiazhuang City to build sports facilities at the new campus of Shijiazhuang Polytechnic Vocational College

Sanai Health Group (01889.HK) plans to sell 59% of Zentrogene Bioscience Laboratory shares for HK$22 million

[Equity Incentives]

Chalk (02469.HK) grants 7 million restricted share units to Wei Liang, co-founder and president of the company

Delin Holdings (01709.HK) grants 200,000 bonus shares

[Issuance of additional shares]

China Party Culture (01532.HK) plans to place up to 296 million shares to raise approximately HK$23.1 million

Qianhai Health (00911.HK) proposes to change the trading unit for each “10 in 1” merger to 10,000 shares

[Increase or decrease holdings]

The controlling shareholder of Dongfeng Group Co., Ltd. (00489.HK) increased its holdings of the company by 3.16 million H shares

[Repurchase Cancellation]

HSBC Holdings (00005.HK) spent HK$226 million to repurchase 3.6 million shares on April 16

Shell-W (02423.HK) spent 10 million US dollars to buy back 2.39 million shares on April 16

Standard Chartered Group (02888.HK) spent £7.84 million to buy back 1,212,000 shares on April 16

Hang Seng Bank (00011.HK) spent HK$574.276 million to repurchase 600,000 shares on April 17

CSPC Group (01093.HK) spent HK$349.29 million to buy back 6 million shares on April 17

Changshi Group (01113.HK) spent HK$26.26 million to buy back 839,500 shares on April 17

Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 477,400 A shares on April 17

Kuaishou-W (01024.HK) spent HK$19.96 million to buy back 435,000 shares on April 17

Swire Group A (00019.HK) spent HK$18.7.309 million to repurchase 309 million shares on April 17

Xiansheng Pharmaceutical (02096.HK) spent HK$16.948,200 to buy back 3.288 million shares on April 17

Jiangxi Copper Co., Ltd. (00358.HK) spent 8.78 million yuan to buy back 341,500 A shares on April 17

Kingdee International (00268.HK) spent HK$7.794 million to buy back 1 million shares on April 17

Kangzhe Pharmaceutical (00867.HK) spent HK$7.423,800 to buy back 1.06 million shares on April 17

Tourover-W (09690.HK) spent HK$6.36 million to buy back 355,400 shares on April 17

Skyworth Group (00751.HK) spent HK$6.193,900 to repurchase 2.03 million shares on April 17

Haitong Securities (06837.HK) spent 5 million yuan to buy back 637,800 A shares on April 17

AIA (01299.HK) spent HK$4.687 million to buy back 100,000 shares on April 17

Yum China (09987.HK) spent HK$4.67 million to buy back 161,000 shares on April 16　

Lianyirong Technology-W (09959.HK) spent HK$4.4916 million to buy back 3.0865 million shares on April 17